LABORIE, a leading developer and manufacturer of medical devices in the pelvic health market, offers a new educational course, “Fecal Incontinence Diagnostics”. This 2-day course is designed to provide health professionals with expanded knowledge of Fecal Incontinence diagnosis and treatment, Anorectal Manometry and Transrectal Ultrasound.
Fecal Incontinence is one of the most psychologically and socially debilitating conditions in an otherwise healthy individual. This Fecal Incontinence course encompasses the basic fundamentals of Anorectal Manometry and Transrectal Ultrasound as well as best practices and specific case studies.
“LABORIE recognizes the need to offer clinically-based educational offerings for Fecal Incontinence diagnostics” stated Peter Bulla, Vice President. “This course adds to our mission to be the leader in Pelvic Health and will help fill the need for more educational opportunities on this topic.”
This course is an addition to our current Educational Course offerings, including various courses on Urodynamics and Pelvic Floor Rehabilitation.
LABORIE (www.laborie.com), headquartered in Toronto, Canada, is a leading multinational developer, manufacturer and marketer of innovative medical equipment and catheters in the pelvic health market for the diagnosis and treatment of Urinary and Fecal Incontinence as well as other pelvic floor disorders.
LABORIE Medical Technologies (“LABORIE”) and Cogentix Medical, Inc. (NASDAQ: CGNT) (“Cogentix”) today announced the completion of the acquisition by LABORIE of Cogentix through LABORIE’S affiliate Camden Merger Sub, Inc. (“Merger Sub”), a wholly owned subsidiary of LM US Parent, Inc. (“Parent”).
LABORIE Medical Technologies (“LABORIE”) announced the successful completion of the tender offer by its affiliate Camden Merger Sub, Inc. (“Merger Sub”), a wholly owned subsidiary of LM US Parent, Inc. (“Parent”) to purchase all outstanding shares of common stock of Cogentix Medical, Inc. (NASDAQ: CGNT) (“Cogentix”)
LABORIE Medical Technologies, a leading global developer and manufacturer of medical diagnostics and devices in the pelvic health and gastroenterology market, today announces the execution of a definitive agreement to acquire Cogentix Medical Inc., (NASDAQ: CGNT)